Main Article Content
Cancer is the world's second largest cause of mortality and one of the most serious public health issues. Despite significant advancements in cancer treatment, cancer incidence and mortality rates remain high. Current research is still focused on developing more effective and less hazardous cancer treatment options. Curcumin has gotten a lot of press in the last two decades as an anti-oxidant, anti-inflammatory and cancer-fighting agent Curcumin modulated intracellular signaling pathways that affect tumor growth, angiogenesis, metastasis, inflammation, invasion, and apoptosis, among other things. Curcumin suppresses tumor cell growth and enhances apoptosis via upregulating the expression and activity of p53. Curcumin also has a strong inhibitory impact on the NFB and COX2 activity, which are involved in the upregulation of antiapoptotic genes like Bcl2. It can also reduce the control of antiapoptosis PI3K signaling and enhance MAPK expression, resulting in endogenous reactive oxygen species generation. The goal of this research is to review curcumin's anticancer properties.
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.